Impact of antihypertensive treatments on erectile responses in aging spontaneously hypertensive rats

Johanna L. Hannan, Corry Smallegange, Taben Hale, Jeremy P W Heaton, Michael A. Adams

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective: We previously demonstrated that brief, aggressive antihypertensive therapy recovered erectile function in 40-week-old spontaneously hypertensive rats (SHR). The present study examined the impact of antihypertensive and testosterone treatments on erectile function in aging SHR. Design and methods: Centrally initiated erections were determined in response to apomorphine throughout. At 30 and 49 weeks, SHR were treated for 2 weeks with enalapril or hydralazine. A third more aggressive treatment (68 weeks) involved enalapril or losartan plus a low salt diet or a triple therapy (hydralazine, nifedipine, hydrochlorothiazide). In a separate study, cross-over kidney transplantations were performed between untreated and losartan-treated SHR. Arterial pressure was assessed posttransplantation using radio-telemetric transducers. Results: There was an age-related decrease in erections between 30 and 68 weeks (3.1 ± 0.79 versus 0.2 ± 0.38) that was not improved by testosterone administration. Early treatment with enalapril or hydralazine did not prevent this decline, although the second treatment resulted in significant improvements (enalapril, 0.8 ± 0.70; hydralazine, 0.8 ± 0.41 versus control, 0.3 ± 0.60). A 2-week aggressive antihypertensive treatment at 68 weeks increased erections approximately two-fold, with the previously treated rats receiving triple therapy having markedly improved erectile responses (0.2 ± 0.53 versus 1.1 ± 1.67). In the transplantation study, previously losartan-treated SHR given an untreated kidney had higher arterial pressure but twice the number of erections in comparison with the SHR with lower arterial pressure resulting from transplanting a treated kidney. Conclusions: Aggressive antihypertensive treatments may be more beneficial in improving erectile function in aged SHR, via an effect that appears to be tissue specific, and not based on changes in blood pressure.

Original languageEnglish (US)
Pages (from-to)159-168
Number of pages10
JournalJournal of Hypertension
Volume24
Issue number1
StatePublished - Jan 2006
Externally publishedYes

Fingerprint

Inbred SHR Rats
Antihypertensive Agents
Hydralazine
Enalapril
Losartan
Arterial Pressure
Therapeutics
Testosterone
Kidney
Sodium-Restricted Diet
Hydrochlorothiazide
Apomorphine
Nifedipine
Transducers
Radio
Kidney Transplantation
Transplantation
Blood Pressure

Keywords

  • Aging
  • Antihypertensive agents
  • Erectile dysfunction
  • Renal
  • Spontaneously hypertensive rats
  • Transplantation

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology

Cite this

Hannan, J. L., Smallegange, C., Hale, T., Heaton, J. P. W., & Adams, M. A. (2006). Impact of antihypertensive treatments on erectile responses in aging spontaneously hypertensive rats. Journal of Hypertension, 24(1), 159-168.

Impact of antihypertensive treatments on erectile responses in aging spontaneously hypertensive rats. / Hannan, Johanna L.; Smallegange, Corry; Hale, Taben; Heaton, Jeremy P W; Adams, Michael A.

In: Journal of Hypertension, Vol. 24, No. 1, 01.2006, p. 159-168.

Research output: Contribution to journalArticle

Hannan, JL, Smallegange, C, Hale, T, Heaton, JPW & Adams, MA 2006, 'Impact of antihypertensive treatments on erectile responses in aging spontaneously hypertensive rats', Journal of Hypertension, vol. 24, no. 1, pp. 159-168.
Hannan, Johanna L. ; Smallegange, Corry ; Hale, Taben ; Heaton, Jeremy P W ; Adams, Michael A. / Impact of antihypertensive treatments on erectile responses in aging spontaneously hypertensive rats. In: Journal of Hypertension. 2006 ; Vol. 24, No. 1. pp. 159-168.
@article{00851a5f77074162927abe6ad029c4b1,
title = "Impact of antihypertensive treatments on erectile responses in aging spontaneously hypertensive rats",
abstract = "Objective: We previously demonstrated that brief, aggressive antihypertensive therapy recovered erectile function in 40-week-old spontaneously hypertensive rats (SHR). The present study examined the impact of antihypertensive and testosterone treatments on erectile function in aging SHR. Design and methods: Centrally initiated erections were determined in response to apomorphine throughout. At 30 and 49 weeks, SHR were treated for 2 weeks with enalapril or hydralazine. A third more aggressive treatment (68 weeks) involved enalapril or losartan plus a low salt diet or a triple therapy (hydralazine, nifedipine, hydrochlorothiazide). In a separate study, cross-over kidney transplantations were performed between untreated and losartan-treated SHR. Arterial pressure was assessed posttransplantation using radio-telemetric transducers. Results: There was an age-related decrease in erections between 30 and 68 weeks (3.1 ± 0.79 versus 0.2 ± 0.38) that was not improved by testosterone administration. Early treatment with enalapril or hydralazine did not prevent this decline, although the second treatment resulted in significant improvements (enalapril, 0.8 ± 0.70; hydralazine, 0.8 ± 0.41 versus control, 0.3 ± 0.60). A 2-week aggressive antihypertensive treatment at 68 weeks increased erections approximately two-fold, with the previously treated rats receiving triple therapy having markedly improved erectile responses (0.2 ± 0.53 versus 1.1 ± 1.67). In the transplantation study, previously losartan-treated SHR given an untreated kidney had higher arterial pressure but twice the number of erections in comparison with the SHR with lower arterial pressure resulting from transplanting a treated kidney. Conclusions: Aggressive antihypertensive treatments may be more beneficial in improving erectile function in aged SHR, via an effect that appears to be tissue specific, and not based on changes in blood pressure.",
keywords = "Aging, Antihypertensive agents, Erectile dysfunction, Renal, Spontaneously hypertensive rats, Transplantation",
author = "Hannan, {Johanna L.} and Corry Smallegange and Taben Hale and Heaton, {Jeremy P W} and Adams, {Michael A.}",
year = "2006",
month = "1",
language = "English (US)",
volume = "24",
pages = "159--168",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Impact of antihypertensive treatments on erectile responses in aging spontaneously hypertensive rats

AU - Hannan, Johanna L.

AU - Smallegange, Corry

AU - Hale, Taben

AU - Heaton, Jeremy P W

AU - Adams, Michael A.

PY - 2006/1

Y1 - 2006/1

N2 - Objective: We previously demonstrated that brief, aggressive antihypertensive therapy recovered erectile function in 40-week-old spontaneously hypertensive rats (SHR). The present study examined the impact of antihypertensive and testosterone treatments on erectile function in aging SHR. Design and methods: Centrally initiated erections were determined in response to apomorphine throughout. At 30 and 49 weeks, SHR were treated for 2 weeks with enalapril or hydralazine. A third more aggressive treatment (68 weeks) involved enalapril or losartan plus a low salt diet or a triple therapy (hydralazine, nifedipine, hydrochlorothiazide). In a separate study, cross-over kidney transplantations were performed between untreated and losartan-treated SHR. Arterial pressure was assessed posttransplantation using radio-telemetric transducers. Results: There was an age-related decrease in erections between 30 and 68 weeks (3.1 ± 0.79 versus 0.2 ± 0.38) that was not improved by testosterone administration. Early treatment with enalapril or hydralazine did not prevent this decline, although the second treatment resulted in significant improvements (enalapril, 0.8 ± 0.70; hydralazine, 0.8 ± 0.41 versus control, 0.3 ± 0.60). A 2-week aggressive antihypertensive treatment at 68 weeks increased erections approximately two-fold, with the previously treated rats receiving triple therapy having markedly improved erectile responses (0.2 ± 0.53 versus 1.1 ± 1.67). In the transplantation study, previously losartan-treated SHR given an untreated kidney had higher arterial pressure but twice the number of erections in comparison with the SHR with lower arterial pressure resulting from transplanting a treated kidney. Conclusions: Aggressive antihypertensive treatments may be more beneficial in improving erectile function in aged SHR, via an effect that appears to be tissue specific, and not based on changes in blood pressure.

AB - Objective: We previously demonstrated that brief, aggressive antihypertensive therapy recovered erectile function in 40-week-old spontaneously hypertensive rats (SHR). The present study examined the impact of antihypertensive and testosterone treatments on erectile function in aging SHR. Design and methods: Centrally initiated erections were determined in response to apomorphine throughout. At 30 and 49 weeks, SHR were treated for 2 weeks with enalapril or hydralazine. A third more aggressive treatment (68 weeks) involved enalapril or losartan plus a low salt diet or a triple therapy (hydralazine, nifedipine, hydrochlorothiazide). In a separate study, cross-over kidney transplantations were performed between untreated and losartan-treated SHR. Arterial pressure was assessed posttransplantation using radio-telemetric transducers. Results: There was an age-related decrease in erections between 30 and 68 weeks (3.1 ± 0.79 versus 0.2 ± 0.38) that was not improved by testosterone administration. Early treatment with enalapril or hydralazine did not prevent this decline, although the second treatment resulted in significant improvements (enalapril, 0.8 ± 0.70; hydralazine, 0.8 ± 0.41 versus control, 0.3 ± 0.60). A 2-week aggressive antihypertensive treatment at 68 weeks increased erections approximately two-fold, with the previously treated rats receiving triple therapy having markedly improved erectile responses (0.2 ± 0.53 versus 1.1 ± 1.67). In the transplantation study, previously losartan-treated SHR given an untreated kidney had higher arterial pressure but twice the number of erections in comparison with the SHR with lower arterial pressure resulting from transplanting a treated kidney. Conclusions: Aggressive antihypertensive treatments may be more beneficial in improving erectile function in aged SHR, via an effect that appears to be tissue specific, and not based on changes in blood pressure.

KW - Aging

KW - Antihypertensive agents

KW - Erectile dysfunction

KW - Renal

KW - Spontaneously hypertensive rats

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=29144497331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29144497331&partnerID=8YFLogxK

M3 - Article

C2 - 16331114

AN - SCOPUS:29144497331

VL - 24

SP - 159

EP - 168

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 1

ER -